Search filters

List of works by Ola Weiland

A low-dose intradermal hepatitis B vaccine programme in health-care workers and students is highly effective and cost saving: a retrospective follow-up survey in the clinical setting

scientific article published in January 2008

A randomized controlled open study of interferon alpha-2b treatment of chronic non-A, non-B posttransfusion hepatitis: no correlation of outcome to presence of hepatitis C virus antibodies

scientific article published on January 1989

A risk for hepatocellular carcinoma persists long-term after sustained virologic response in patients with hepatitis C-associated liver cirrhosis

scientific article

ABT-450, ritonavir, ombitasvir, and dasabuvir achieves 97% and 100% sustained virologic response with or without ribavirin in treatment-experienced patients with HCV genotype 1b infection.

scientific article published on 9 May 2014

Alpha interferon treatment of chronic non-A, non-B hepatitis caused by intravenous gammaglobulin

scientific article published in January 1988

An epidemic outbreak of hepatitis A among homosexual men in Stockholm. Hepatitis A, a special hazard for the male homosexual subpopulation in Sweden

scientific article published on 01 October 1982

Antibodies to Recombinant and Synthetic Peptides Derived from the Hepatitis C Virus Genome in Long-Term-Studied Patients with Posttransfusion Hepatitis C ⬇️

scientific article published on December 1, 1991

Application of a numerical scoring system for assessment of histological outcome in patients with chronic posttransfusion non-A, non-B hepatitis with or without antibodies to hepatitis C.

scientific article published on October 1990

Autoimmune chronic active hepatitis: changing reactivity for antibodies to hepatitis C virus after immunosuppressive treatment

scientific article published on November 1990

Breakthrough in the treatment of chronic hepatitis C virus infections. Direct acting antivirals heals over 90 percent

scientific article published on 19 November 2014

Can HCV infection be cleared?

scientific article published on August 1998

Cell-mediated immune responses and loss of hepatitis B e-antigen (HBeAg) during successful lamivudine and famciclovir combination therapy for chronic replicating hepatitis B virus infection

scientific article published in December 1999

Changes of serum neopterin, beta 2-microglobulin and interferon-gamma in patients with chronic hepatitis C treated with interferon-alpha 2b

scientific article published on July 1, 1992

Characteristics and long-term outcome of patients with autoimmune hepatitis related to the initial treatment response

scientific article

Chronic hepatitis C--Swedish experts' meeting recommends combination treatment

scientific article published in January 2000

Chronic hepatitis C: updated Swedish consensus

scientific article published on January 2003

Cirrhosis, high age and high body mass index are risk factors for persisting advanced fibrosis after sustained virologic response in chronic hepatitis C.

scientific article published on 6 February 2018

Clinical significance of residual viremia detected by two real-time PCR assays for response-guided therapy of HCV genotype 1 infection

scientific article published on 11 January 2014

Codon optimization and mRNA amplification effectively enhances the immunogenicity of the hepatitis C virus nonstructural 3/4A gene

scientific article published on March 2004

Colorimetric detection of competitive PCR products for quantification of hepatitis C viremia

scientific article published in April 1994

Combination treatment with interferon alfa-2b and ribavirin for chronic hepatitis C in patients who have failed to achieve sustained response to interferon alone: Swedish experience.

scientific article published on January 1995

Combined treatment with interferon alpha-2b and ribavirin for chronic hepatitis C in patients with a previous non-response or non-sustained response to interferon alone

scientific article published in May 1995

Comparison of 3 quantitative HCV RNA assays--accuracy of baseline viral load to predict treatment outcome in chronic hepatitis C.

scientific article published in January 1998

Concentration-guided ribavirin dosing with darbepoetin support and peg-IFN alfa-2a for treatment of hepatitis C recurrence after liver transplantation

scientific article published on 17 February 2012

Containing "The Great Houdini" of viruses: combining direct acting antivirals with the host immune response for the treatment of chronic hepatitis C.

scientific article published on July 2013

Corrigendum to “SHORT STATEMENT OF THE FIRST EUROPEAN CONSENSUS CONFERENCE ON THE TREATMENT OF CHRONIC HEPATITIS B AND C IN HIV CO-INFECTED PATIENTS”[J Hepatol 42 (2005) 615–624]

article

DNA vaccine therapy for chronic hepatitis C virus (HCV) infection: immune control of a moving target.

scientific article published on July 2009

Daclatasvir combined with sofosbuvir or simeprevir in liver transplant recipients with severe recurrent hepatitis C infection

scientific article published on 17 February 2016

Daclatasvir plus peginterferon alfa and ribavirin for treatment-naive chronic hepatitis C genotype 1 or 4 infection: a randomised study

scientific article published on 30 July 2014

Daclatasvir plus sofosbuvir, with or without ribavirin, achieved high sustained virological response rates in patients with HCV infection and advanced liver disease in a real-world cohort

scientific article published on 07 September 2016

Detection of hepatitis C viral RNA by the polymerase chain reaction in serum of patients with post-transfusion non-A, non-B hepatitis ⬇️

scientific article published on May 1, 1992

Detection of hepatitis C virus (HCV) RNA by PCR related to HCV antibodies in serum and liver histology in swedish blood donors ⬇️

scientific article published on January 1, 1993

Diabetes and Cirrhosis Are Risk Factors for Hepatocellular Carcinoma After Successful Treatment of Chronic Hepatitis C.

scientific article

Distinguishing acute from symptomatic chronic hepatitis C virus (HCV) infection by site-directed serology of the HCV structural proteins

scientific article published in May 1995

Dynamic tailoring of treatment durations improves efficiency of hepatitis C treatment with pegylated interferon and ribavirin.

scientific article published on 16 October 2012

Editorial - An introduction to the new INFECTIOUS DISEASES

scientific article published on 01 December 2014

Effect of control selection on sustained viral response rates in genotype 2/3 HCV mono-infected versus HIV/HCV co-infected patients

scientific article published in July 2010

Efficacy of 24 weeks treatment with peginterferon alfa-2b plus ribavirin in patients with chronic hepatitis C infected with genotype 1 and low pretreatment viremia

scientific article published on 7 November 2005

Efficacy of human leucocyte alpha-interferon treatment for chronic hepatitis C virus infection

scientific article

Efficacy of human leucocyte alpha-interferon treatment for chronic hepatitis C virus infection.

scientific article published on January 1995

Elevated numbers of Fc gamma RIIIA+ (CD16+) effector CD8 T cells with NK cell-like function in chronic hepatitis C virus infection.

scientific article published on September 2008

Epidemiology and causes of death in a Swedish cohort of patients with autoimmune hepatitis

scientific article published on 31 May 2017

Epidemiology and the initial presentation of autoimmune hepatitis in Sweden: A nationwide study

scientific article published on 01 January 2008

Evaluation of an oral bile acid loading test for assessment of liver function in chronic hepatitis. A comparison with fasting serum bile acids and i.v. galactose elimination test

scientific article published in April 1987

Evidence for a relation between the viral load and genotype and hepatitis C virus-specific T cell responses

scientific article published on June 2004

Evolution of fibrosis during HCV recurrence after liver transplantation--influence of IL-28B SNP and response to peg-IFN and ribavirin treatment

scientific article published on 23 April 2013

Expansion of functionally skewed CD56-negative NK cells in chronic hepatitis C virus infection: correlation with outcome of pegylated IFN-alpha and ribavirin treatment

scientific article published on 21 October 2009

Factors influencing the response to interferon therapy in chronic hepatitis C. Studies on viral genotype and induction of 2',5'-oligoadenylate synthetase in the liver and peripheral blood cells

scientific article published on June 1996

False positive reactivity for antibodies against hepatitis C virus in patients with autoimmune chronic active hepatitis?

scientific article published in January 1990

Features of the CD4+ T-cell response in liver and peripheral blood of hepatitis C virus-infected patients with persistently normal and abnormal alanine aminotransferase levels

scientific article published in March 2002

GB virus C/hepatitis G virus

scientific article published on 01 January 2001

GBV-C/HGV infection in hepatitis C virus-infected deferred Swedish blood donors

scientific article published on February 1998

Genotyping of hepatitis C virus isolates by a modified polymerase chain reaction assay using type specific primers: epidemiological applications

scientific article published on November 1994

Genotyping of hepatitis C virus performed by type-specific PCR in comparison to nucleotide sequencing of NS5 and core regions

scientific article published on May 1997

Give all children vaccine against hepatitis B!

scientific article published in September 2001

Glecaprevir/Pibrentasvir in Patients with Chronic HCV Genotype 3 Infection: An Integrated Phase 2/3 Analysis

scientific article published on 11 December 2018

HCV RNA decline in chronic HCV genotype 2 and 3 during standard of care treatment according to IL28B polymorphism

scientific article published on 21 August 2012

HCV genotypes in Swedish blood donors as correlated to epidemiology, liver disease and hepatitis C virus antibody profile

scientific article published in September 1995

Half of the patients respond to interferon treatment. Combination therapy is an alternative in chronic hepatitis C

scientific article published in May 1995

Health-related quality of life before, during and after combination therapy with interferon and ribavirin in unselected Swedish patients with chronic hepatitis C.

scientific article published in May 2006

Hepatic and extrahepatic malignancies in autoimmune hepatitis. A long-term follow-up in 473 Swedish patients

scientific article published on 06 November 2008

Hepatitis C elimination - Macro-elimination

scientific article published on 01 February 2020

Hepatitis C viral RNA titers in serum prior to, during, and after oral treatment with ribavirin for chronic hepatitis C.

scientific article published in October 1993

Hepatitis C virus RNA kinetics during the initial 12 weeks treatment with pegylated interferon-alpha 2a and ribavirin according to virological response

scientific article published in September 2005

Hepatitis C virus RNA levels during initial induction or standard interferon therapy: influence of continued treatment on sustained response

scientific article published in January 2003

Hepatitis C virus kinetics during induction and standard 3 times a week interferon-alpha therapy

scientific article published in January 2001

Hepatitis C virus replication in liver and peripheral blood mononuclear cells of interferon-alpha-treated and untreated patients with chronic hepatitis C.

scientific article published in January 1994

Hepatitis C: virology, epidemiology, clinical course, and treatment

scientific article published on May 1, 1992

Hepatitis E virus infections in patients with acute hepatitis non-A-D in Sweden

scientific article published on January 1995

Hepatocellular and extrahepatic cancer in patients with autoimmune hepatitis--a long-term follow-up study in 634 Swedish patients

scientific article published on 8 December 2014

High HCV treatment uptake in the Swedish HIV/HCV co-infected cohort

scientific article published on July 2014

High adherence with a low initial ribavirin dose in combination with pegylated-IFN alpha-2a for treatment of recurrent hepatitis C after liver transplantation

scientific article published on 6 September 2007

High sustained response rate and clearance of viremia in chronic hepatitis C after treatment with interferon-alpha 2b for 60 weeks

scientific article published in February 1994

High-Dose Ribavirin Enhances Early Virological Response in Hepatitis C Genotype 1-Infected Patients

scientific article published on 24 March 2015

Histological and virological long-term outcome in patients treated with interferon-alpha2b and ribavirin for chronic hepatitis C.

scientific article published in May 1999

Histological findings, genotype distribution and percentage of patients fulfilling the treatment criteria among patients with chronic hepatitis C virus infection in a single Swedish centre

scientific article published on February 2004

Histological improvement of liver fibrosis in well-treated patients with autoimmune hepatitis: A cohort study

scientific article published on August 2017

Histological outcome in interferon alpha-2b treated patients with chronic posttransfusion non-A, non-B hepatitis.

scientific article published on February 1991

Histological outcome in patients with chronic hepatitis C given a 60-week interferon alfa-2b treatment course

scientific article published in August 1994

Human and murine antibody recognition is focused on the ATPase/helicase, but not the protease domain of the hepatitis C virus nonstructural 3 protein

scientific article published on July 1998

Humoral and CD4(+) T helper (Th) cell responses to the hepatitis C virus non-structural 3 (NS3) protein: NS3 primes Th1-like responses more effectively as a DNA-based immunogen than as a recombinant protein

scientific article published in June 2001

Humoral and cellular immune responses to the GB virus C/hepatitis G virus envelope 2 protein

scientific article published in November 2000

IgM-antibody response to hepatitis C virus antigens in acute and chronic post-transfusion non-A, non-B hepatitis ⬇️

scientific article published on December 1, 1991

Impact of Il28b-related single nucleotide polymorphisms on liver transient elastography in chronic hepatitis C infection

scientific article

In memoriam--Professor Ragnar Norrby (1943-2014).

scientific article published on August 2014

Incidence and outcome of Staphylococcus aureus endocarditis--a 10-year single-centre northern European experience

scientific article published on 28 April 2015

Incidence and spontaneous clearance of hepatitis C virus (HCV) in people who inject drugs at the Stockholm Needle Exchange-Importance for HCV elimination

scientific article published on 30 July 2018

Incidence of hepatitis and seroconversion to hepatitis C virus after open-heart surgery in transfused and non-transfused patients in sweden ⬇️

scientific article published on January 1, 1991

Infectious aetiology of jaundice among pregnant women in Angola

scientific article

Influence of pre-treatment factors on outcome of interferon-alpha treatment of patients with chronic hepatitis C.

scientific article published in January 1999

Interferon alpha-2b treatment of chronic posttransfusion non-A, non-B/C hepatitis: long-term outcome and effect of increased interferon doses in non-responders

scientific article

Interferon-alpha treatment induces delayed CD4 proliferative responses to the hepatitis C virus nonstructural protein 3 regardless of the outcome of therapy

scientific article published on June 1997

Interferon-ribavirin combination therapy for chronic hepatitis C.

scientific article published on December 1996

Interferon-ribavirin for chronic hepatitis C with and without cirrhosis: analysis of individual patient data of six controlled trials. Eurohep Study Group for Viral Hepatitis.

scientific article

Lamivudine and famciclovir combination therapy with or without addition of interferon-alpha-2b for HBeAg-positive chronic hepatitis B: a pilot study

scientific article published in January 2002

Limitations of commercial test for antibody to hepatitis A virus ⬇️

scientific article published on January 27, 1979

Limited humoral immunity in hepatitis C virus infection

scientific article published in January 1999

Liver Transplantation for HCV Cirrhosis at Karolinska University Hospital Huddinge, Stockholm

scientific article published on 01 October 2006

Long term clinical outcome of chronic hepatitis C patients with sustained virological response to interferon monotherapy.

scientific article published on October 2004

Long-Term Outcome of Liver Transplantation in HIV-1-Positive Patients: 15-Year Follow-Up

article

Long-term follow-up of 60 patients with chronic hepatitis B. I. Seroconversion in the hepatitis B e-system, frequency of delta infection and histological outcome

scientific article published in February 1986

Long-term follow-up of 60 patients with chronic hepatitis B. II. Hepatitis B virus DNA in serum correlated to the hepatitis Be-system and presence of delta superinfection

scientific article

Long-term follow-up of chronic hepatitis C patients with sustained virological response to alpha-interferon

scientific article published in May 1999

Long-term follow-up of chronic post-transfusion non-A, non-B hepatitis: clinical and histological outcome

scientific article published on June 1988

Long-term follow-up of successful hepatitis C virus therapy: waning immune responses and disappearance of liver disease are consistent with cure.

scientific article published on 28 January 2015

Long-term histological outcome in patients with chronic hepatitis C treated repeatedly with interferon alpha-2b without sustained response

scientific article published in January 1994

Long-term study of hepatitis D infection at secondary care centers: the impact of viremia on liver-related outcomes

scientific article published on 07 March 2020

Long-term treatment with interferon-alpha can induce sarcoidosis. The connection can be stronger than earlier believed

scientific article published in June 2006

Low levels of microbial translocation marker LBP are associated with sustained viral response after anti-HCV treatment in HIV-1/HCV co-infected patients.

scientific article

Low liver stiffness among cirrhotic patients with hepatitis B after prolonged treatment with nucleoside analogs

article

Low mortality but increasing incidence of Staphylococcus aureus endocarditis in people who inject drugs: Experience from a Swedish referral hospital.

scientific article published on December 2016

Low mortality of Staphylococcus aureus bacteremia in Icelandic children: nationwide study on incidence and outcome

scientific article published on February 2015

Lower-than-standard dose peg-IFN alfa-2a for chronic hepatitis C caused by genotype 2 and 3 is sufficient when given in combination with weight-based ribavirin

scientific article published on 27 May 2008

Lymphocyte subsets and beta 2-microglobulin expression in chronic hepatitis C/non-A, non-B. Effects of interferon-alpha treatment

scientific article published on March 1, 1992

New pieces to the hepatitis C treatment puzzle

scientific article published on 01 September 2000

Non-A, non-B hepatitis after open-heart surgery in Stockholm: declining incidence after introduction of restrictions for blood donations due to the human immunodeficiency virus

scientific article

Occasional spontaneous clearance of chronic hepatitis C virus in HIV-infected individuals

scientific article published on 18 June 2014

Outcome of acute symptomatic non-A, non-B hepatitis: a 13-year follow-up study of hepatitis C virus markers

scientific article published in October 1993

Patient-reported outcomes assessment in chronic hepatitis C treated with sofosbuvir and ribavirin: the VALENCE study

scientific article published on 5 April 2014

Peg-IFN and ribavirin treatment for recurrence of genotype 2 and 3 hepatitis C after liver transplantation

scientific article published on 4 February 2015

Pegylated interferon and ribavirin combination therapy for chronic hepatitis C virus infection in patients with Child-Pugh Class A liver cirrhosis.

scientific article published in January 2008

Peripheral blood lymphocyte subsets in patients with chronic hepatitis C--effects of interferon treatment

scientific article published on August 1, 1992

Positive reactivity with anti-HCV Elisa in patients with autoimmune hepatitis—Not confirmed with a neutralization test ⬇️

scientific article published on January 1, 1991

Prediction of sustained virological response in chronic hepatitis C patients treated with peginterferon alfa-2a (40KD) and ribavirin

scientific article published in February 2007

Predictive value of ALT levels for histologic findings in chronic hepatitis C: a European collaborative study

scientific article published in October 2002

Prevalence and comorbidities of chronic hepatitis C: a nationwide population-based register study in Sweden

scientific article published on 6 September 2016

Prevalence of antibodies against hepatitis C virus infection among health care workers in Stockholm

scientific article published in April 1994

Prevalence of hepatitis B virus markers among intravenous drug abusers in Stockholm: impact of heterosexual transmission

scientific article published in January 1993

Prevalence of hepatitis B virus markers and exposure to occupational risks likely to be associated with acquisition of hepatitis B virus among health care workers in Stockholm

scientific article published on March 1, 1992

Prevalence of hepatitis B virus markers in Icelandic outpatients and hospital personnel in 1979 and in 1987.

scientific article published in January 1990

Prevalence of hepatitis B virus markers in Sweden: a community-based serosurvey of 4,000 young Swedish adults

scientific article published on February 1992

Prevalence of hepatitis C and pre-testing awareness of hepatitis C status in 1500 consecutive PWID participants at the Stockholm needle exchange program

scientific article published on 2 June 2017

Productivity improvements in hepatitis C treatment: impact on efficacy, cost, cost-effectiveness and quality of life

scientific article published on July 2007

Randomised, double-blind, placebo-controlled trial of interferon alpha-2b with and without ribavirin for chronic hepatitis C. The Swedish Study Group

scientific article published on January 1998

Rapid viral response and treatment outcome in genotype 2 and 3 chronic hepatitis C: comparison between two HCV RNA quantitation methods

scientific article published in May 2008

Recommendations from a Swedish meeting of experts. Hepatitis C is to be treated with the combination of interferon and ribavirin

scientific article published in November 1999

Reduced work absenteeism in patients with hepatitis C treated with second-generation direct-acting antivirals

scientific article published on 08 September 2020

Relation between viral fitness and immune escape within the hepatitis C virus protease

scientific article

Response to a booster dose 18 months after a low anti-HBs response (10-99 IU/l) to three doses of intradermally or intramuscularly administered recombinant hepatitis B vaccine

scientific article published on 01 January 1995

Restriction of hepatitis C virus heterogeneity during prolonged interferon-alpha therapy in relation to changes in virus load

scientific article published in April 1996

Ribavirin enhances the efficacy but not the adverse effects of interferon in chronic hepatitis C. Meta-analysis of individual patient data from European centers.

scientific article published on May 1997

Ribavirin treatment for chronic hepatitis C ⬇️

scientific article published on May 4, 1991

Ribavirin treatment for patients with chronic hepatitis C: results of a placebo-controlled study

scientific article published on November 1996

Risk factors for hepatitis A, B and C virus infection among Swedish expatriates

scientific article published in November 1995

Risk of cirrhosis-related complications in patients with advanced fibrosis following hepatitis C virus eradication.

scientific article

Second-generation hepatitis C Elisa antibody tests confirmed by the four-antigen recombinant immunoblot assay correlate well with hepatitis C viremia and chronic liver disease in Swedish blood donors

scientific article published in January 1993

Seroconversion after additional vaccine doses to non-responders to three doses of intradermally or intramuscularly administered recombinant hepatitis B vaccine

scientific article

Seroconversion to hepatitis C virus antibodies in patients with acute posttransfusion non-A, non-B hepatitis in Sweden

scientific article published on September 1991

Seroconversion to hepatitis C virus antibodies in patients with acute posttransfusion non-A, non-B hepatitis in Sweden with a second generation test

scientific article published on January 1, 1992

Serum ALT levels as a surrogate marker for serum HBV DNA levels in HBeAg-negative pregnant women

scientific article published in January 2004

Serum HCV RNA levels in patients with chronic hepatitis C given a second course of interferon alpha-2b treatment after relapse following initial treatment

scientific article published in January 1993

Serum hepatitis C virus RNA levels in chronic hepatitis C--importance for outcome of interferon alfa-2b treatment

scientific article published in January 1994

Serum levels of anti-NS4a and anti-NS5a predict treatment response of patients with chronic hepatitis C.

scientific article published in June 2007

Serum levels of the aminoterminal propeptide of type III procollagen and hyaluronan during resolving and nonresolving posttransfusion non-A, non-B hepatitis

scientific article published on January 1990

Short statement of the first European Consensus Conference on the treatment of chronic hepatitis B and C in HIV co-infected patients

scientific article

Should hepatitis B vaccination be introduced into childhood immunisation programmes in northern Europe?

scientific article published on June 2007

Significant decrease in injection risk behaviours among participants in a needle exchange programme

scientific article published on 19 February 2020

Simeprevir versus telaprevir with peginterferon and ribavirin in previous null or partial responders with chronic hepatitis C virus genotype 1 infection (ATTAIN): a randomised, double-blind, non-inferiority phase 3 trial

scientific article published on 5 December 2014

Similar hepatitis C virus RNA kinetics in HIV/hepatitis C virus monoinfected genotype 2 or 3 matched controls during hepatitis C virus combination therapy

scientific article published on April 2008

Sofosbuvir and ribavirin in HCV genotypes 2 and 3.

scientific article published on 4 May 2014

Sofosbuvir based treatment of chronic hepatitis C genotype 3 infections-A Scandinavian real-life study.

scientific article published on 13 July 2017

Sofosbuvir/velpatasvir for the treatment of HCV: excellent results from a phase-3, open-label study in Russia and Sweden

scientific article published on 30 November 2018

Staphylococcus aureus bacteraemia and endocarditis - epidemiology and outcome: a review

scientific article published on 6 November 2017

Sulfur amino acid metabolism in hepatobiliary disorders

scientific article published on May 1, 1992

Survival and histological resolution of fibrosis in patients with autoimmune chronic active hepatitis

scientific article published in April 1993

Telaprevir alone or with peginterferon and ribavirin reduces HCV RNA in patients with chronic genotype 2 but not genotype 3 infections

scientific article published on 31 May 2011

The GB virus C/hepatitis G virus replicates in hepatocytes without causing liver disease in healthy blood donors

scientific article published on 18 October 2000

The anti-HBs response after 2 different accelerated intradermal and intramuscular schemes for hepatitis B vaccination.

scientific article

The antiviral compound ribavirin modulates the T helper (Th) 1/Th2 subset balance in hepatitis B and C virus-specific immune responses

scientific article published on October 1998

The dynamic relationship between innate immune biomarkers and interferon-based treatment effects and outcome in hepatitis C virus infection is altered by telaprevir

scientific article

The effectiveness of daclatasvir based therapy in European patients with chronic hepatitis C and advanced liver disease

scientific article

The risk of disease transmission via blood and blood products is always there. It is important for prevention to be a step ahead

scientific article published in January 1999

Therapeutic DNA vaccination using in vivo electroporation followed by standard of care therapy in patients with genotype 1 chronic hepatitis C.

scientific article published on 11 June 2013

Therapy of chronic post-transfusion non-A, non-B hepatitis with interferon alfa-2b: Swedish experience

scientific article published in January 1990

Therapy of hepatitis C: alpha interferon and ribavirin

scientific article published on September 1997

Treatment of HCV with ABT-450/r-ombitasvir and dasabuvir with ribavirin

scientific article published on 10 April 2014

Treatment of chronic hepatitis B infection: an update of Swedish recommendations

scientific article published on January 2008

Treatment of chronic replicative hepatitis B virus infection with short-term continuous infusion of foscarnet

scientific article

Treatment of hepatitis C virus infection for adults and children: Updated Swedish consensus recommendations.

scientific article published on December 2015

Treatment of hepatitis C virus infection for adults and children: updated Swedish consensus guidelines 2017.

scientific article published in March 2018

Treatment of hepatitis C virus infection in adults and children: updated Swedish consensus recommendations

scientific article published on 16 April 2012

Treatment of hepatitis C virus infection: updated Swedish Consensus recommendations

scientific article

Treatment of hepatitis C virus infection: updated Swedish Guidelines 2016.

scientific article published on 15 March 2017

Treatment response in chronic hepatitis C. Content of virus in serum is decisive for the outcome

scientific article published in January 1998

Two-year biochemical, virological, and histological follow-up in patients with chronic hepatitis C responding in a sustained fashion to interferon alfa-2b treatment

scientific article published in April 1995

Unexpected high prevalence of IgG-antibodies to hepatitis E virus in Swedish pig farmers and controls

scientific article published in January 2006

Utility of an anonymous questionnaire for the identification of a primary transmission route and possible secondary transmission in adults with acute hepatitis B virus infection

scientific article published on June 1996

Variation in the hepatitis C virus NS5a region in relation to hypervariable region 1 heterogeneity during interferon treatment

scientific article published on September 1998

Viral kinetics and treatment response in patients with hepatitis C during induction and standard interferon therapy in combination with ribavirin

scientific article published in October 2002

What offers the best prediction of sustained virologic response during combination therapy with interferon and ribavirin: viral dynamics, viral levels at certain time points, or a combination of both?

scientific article published on 17 April 2009

Yersinia enterocolitica septicemia: clinical and microbiological aspects

scientific article

[Blood exposure during labor. A common risk of contamination that may be reduced]

scientific article published on 01 April 1997

[Elastography--a new tool for diagnosis of chronic liver diseases. Might replace liver biopsy, but not always]

scientific article published on 01 December 2009

[Fibrosis indexes reduce the need of liver biopsy in chronic hepatitis C]

scientific article published on 01 April 2009

[Hepatitis B is an occupational risk for health personnel. Preventive vaccination is recommended]

scientific article published on 01 March 1996

[Immunoglobulin or vaccine as post-exposure prophylaxis against hepatitis A. The vaccine is sufficient for many according to the first controlled study]

scientific article published on 01 May 2008

[Measurement of liver elasticity can differentiate high and low grade fibrosis. New method can reduce the need of liver biopsy in chronic hepatitis C]

scientific article published on 01 December 2009

Paulina is supported by:

About Paulina

Help